Follow
Emily Hankosky
Title
Cited by
Cited by
Year
Chronic stress causes amygdala hyperexcitability in rodents
JA Rosenkranz, ER Venheim, M Padival
Biological psychiatry 67 (12), 1128-1136, 2010
3012010
The changing landscape of naloxone availability in the United States, 2011–2017
PR Freeman, ER Hankosky, MR Lofwall, JC Talbert
Drug and alcohol dependence 191, 361-364, 2018
902018
Age and sex differences in behavioral flexibility, sensitivity to reward value, and risky decision-making.
SR Westbrook, ER Hankosky, MR Dwyer, JM Gulley
Behavioral Neuroscience 132 (2), 75, 2018
412018
Age of exposure-dependent effects of amphetamine on behavioral flexibility
ER Hankosky, NM Kofsky, JM Gulley
Behavioural brain research 252, 117-125, 2013
362013
Performance on an impulse control task is altered in adult rats exposed to amphetamine during adolescence
ER Hankosky, JM Gulley
Developmental psychobiology 55 (7), 733-744, 2013
332013
Pharmacological enhancement of calcium-activated potassium channel function reduces the effects of repeated stress on fear memory
D Atchley, ER Hankosky, K Gasparotto, JA Rosenkranz
Behavioural brain research 232 (1), 37-43, 2012
272012
Beta-hydroxy-beta-methylbutyrate ameliorates aging effects in the dendritic tree of pyramidal neurons in the medial prefrontal cortex of both male and female rats
DG Kougias, SO Nolan, WA Koss, T Kim, ER Hankosky, JM Gulley, ...
Neurobiology of aging 40, 78-85, 2016
262016
Effects of β-hydroxy-β-methyl butyrate on working memory and cognitive flexibility in an animal model of aging
ER Hankosky, LK Sherrill, LA Ruvola, RM Haake, T Kim, LR Hammerslag, ...
Nutritional Neuroscience 20 (7), 379-387, 2017
242017
D1 receptor-mediated inhibition of medial prefrontal cortex neurons is disrupted in adult rats exposed to amphetamine in adolescence
S Kang, K Paul, ER Hankosky, CL Cox, JM Gulley
Neuroscience 324, 40-49, 2016
212016
Risk factors associated with COVID-19 hospitalization and mortality: a large claims-based analysis among people with type 2 diabetes mellitus in the United States
KS Boye, E Tokar Erdemir, N Zimmerman, A Reddy, BD Benneyworth, ...
Diabetes Therapy 12, 2223-2239, 2021
202021
Age-and sex-dependent effects of methamphetamine on cognitive flexibility and 5-HT2C receptor localization in the orbitofrontal cortex of Sprague-Dawley rats
ER Hankosky, SR Westbrook, RM Haake, J Willing, LT Raetzman, ...
Behavioural brain research 349, 16-24, 2018
182018
X-search: an open access interface for cross-cohort exploration of the National Sleep Research Resource
L Cui, N Zeng, M Kim, R Mueller, ER Hankosky, S Redline, GQ Zhang
BMC medical informatics and decision making 18, 1-10, 2018
162018
Retrospective analysis of health claims to evaluate pharmacotherapies with potential for repurposing: Association of bupropion and stimulant use disorder remission
ER Hankosky, HM Bush, LP Dwoskin, DR Harris, DW Henderson, ...
AMIA Annual Symposium Proceedings 2018, 1292, 2018
162018
Reduced sensitivity to reinforcement in adolescent compared to adult Sprague-Dawley rats of both sexes
ER Hankosky, SR Westbrook, RM Haake, M Marinelli, JM Gulley
Psychopharmacology 235, 861-871, 2018
152018
Beta-hydroxy-beta-methylbutyrate (HMB) ameliorates age-related deficits in water maze performance, especially in male rats
DG Kougias, ER Hankosky, JM Gulley, JM Juraska
Physiology & behavior 170, 93-99, 2017
142017
Association between state Medicaid expansion status and naloxone prescription dispensing
M Sohn, JC Talbert, C Delcher, ER Hankosky, MR Lofwall, PR Freeman
Health services research 55 (2), 239-248, 2020
132020
Predicting substance use disorder using long-term attention deficit hyperactivity disorder medication records in Truven
S Fouladvand, ER Hankosky, H Bush, J Chen, LP Dwoskin, PR Freeman, ...
Health informatics journal 26 (2), 787-802, 2020
112020
Tirzepatide 10 and 15 mg compared with semaglutide 2.4 mg for the treatment of obesity: an indirect treatment comparison
CW le Roux, ER Hankosky, D Wang, R Malik, M Yu, A Hickey, H Kan, ...
Diabetes, Obesity and Metabolism 25 (9), 2626-2633, 2023
82023
Tirzepatide reduces the predicted risk of atherosclerotic cardiovascular disease and improves cardiometabolic risk factors in adults with obesity or overweight: SURMOUNT‐1 post …
ER Hankosky, H Wang, LM Neff, H Kan, F Wang, NN Ahmad, R Griffin, ...
Diabetes, Obesity and Metabolism 26 (1), 319-328, 2024
72024
Tirzepatide reduces the predicted risk of developing type 2 diabetes in people with obesity or overweight: Post hoc analysis of the SURMOUNT‐1 trial
ER Hankosky, H Wang, LM Neff, H Kan, F Wang, NN Ahmad, A Stefanski, ...
Diabetes, Obesity and Metabolism 25 (12), 3748-3756, 2023
52023
The system can't perform the operation now. Try again later.
Articles 1–20